Eisai
4523.T
#2180
Rank
S$11.09 B
Marketcap
S$39.37
Share price
-0.72%
Change (1 day)
4.02%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): S$1.14

According to Eisai's latest financial reports the company's current EPS (TTM) is S$1.11. an increase over its 2024 EPS that were of S$1.25.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025S$1.4011.85%
2024S$1.25-32.63%
2023S$1.855.52%
2022S$1.76-74.01%
2021S$6.76-66.58%
2020S$20.2298.24%
2019S$10.2017.01%
2018S$8.7237.78%
2017S$6.33-27.62%
2016S$8.7435.33%
2015S$6.46-2.82%
2014S$6.65-27.66%
2013S$9.19-27.49%
2012S$12.67-12.67%
2011S$14.5188.08%
2010S$7.72-11.06%
2009S$8.68-390.15%
2008S-$2.99-127.78%
2007S$10.7711.78%
2006S$9.634.38%
2005S$9.237.4%
2004S$8.5943.03%
2003S$6.0125.09%
2002S$4.8052.67%
2001S$3.1569.76%
2000S$1.85